Table 3.
Baseline Allostatic Load Components by Exercise Intervention Arm
| Variables | Supervised | Home Based | Control | p-value | |||
|---|---|---|---|---|---|---|---|
|
|
|||||||
| Baseline, mean (SD) | 6month change, mean (%)** | Baseline, mean (SD) | 6month change, mean (%) | Baseline, mean (SD) | 6month change, mean (%) | ||
| Cardiovascular markers | |||||||
| Systolic blood pressure* (mm Hg) | 126.33 (14.65) | −1.07 (−0.85) | 134.81 (16.19) | −1.15 (−0.86) | 134.83 (19.62) | 3.24 (2.40) | PC-H=0.150 PC-S=0.005 PH-S=0.148 |
| Diastolic blood pressure (mm Hg) | 79.60 (8.67) | −0.72 (−0.90) | 84 (11.84) | −1.58 (−1.89) | 83.28 (11.57) | 0.27 (0.33) | PC-H=0.494 PC-S=0.089 PH-S=0.304 |
| HDL (mg/dl) | 59.64 (17.48) | 4.80 (8.05) | 59.86 (18.91) | 4.01 (6.70) | 61.04 (18.67) | 0.46 (0.75) | PC-H=0.451 PC-S=0.190 PH-S=0.572 |
| CRP (mg/l) | 8.38 (12.11) | −1.47 (− 17.58) | 9.03 (15.65) | −3.38 (−37.37) | 7.56 (10.44) | −1.00 (−13.27) | PC-H=0.374 PC-S=0.731 PH-S=0.221 |
| Metabolic Markers | |||||||
| Body Mass Index | 35.23 (6.09) | 0.29 (0.83) | 36.02 (7.22) | −1.45 (−4.02) | 36.29 (8.02) | 0.61 (1.68) | PC-H=0.231 PC-S=0.991 PH-S=0.235 |
| Waist circumference (cm) | 107.99 (14.31) | −1.37 (−1.26) | 109.61 (13.15) | −1.46 (−1.33) | 110.70 (14.58) | −0.28 (−0.25) | PC-H=0.911 PC-S=0.471 PH-S=0.546 |
| High plasma glucose (mg/dl) | 103.44 (13.68) | −0.24 (−0.24) | 102.83 (13.37) | −1.21 (−1.17) | 102.32 (12.93) | 0.77 (0.75) | PC-H=0.544 PC-S=0.875 PH-S=0.665 |
| Triglycerides (mg/dl) | 109.00 (67.84) | 5.81 (5.33) | 114.20 (54.88) | −2.26 (−1.98) | 116.71 (65.38) | 0.81 (0.69) | PC-H=0.634 PC-S=0.824 PH-S=0.807 |
*
PC-S=0.005, P values for comparing the changes adjusting for baseline values of the outcomes; PC-H: home-based vs. control group; PC-S: supervised vs. control group; PH-S: home-based vs. supervised group
**
6-month percent change is calculated by subtracting the baseline value from the 6-month follow-up value divided by the baseline value; and expressed as a %